16Apr/13

£1 million for Southampton lymphoma drug research – Leukaemia & Lymphoma Research


Leukaemia & Lymphoma Research

£1 million for Southampton lymphoma drug research
Leukaemia & Lymphoma Research
The introduction of a monoclonal antibody called rituximab over a decade ago heralded their use as an effective treatment for cancer. It doubled the long-term survival rates for many different types of lymphoma when used in combination with chemotherapy.

and more »

16Apr/13

Research and Markets: Chronic Heart Failure – Pipeline Review, H1 2013 – Fort Mills Times

Research and Markets: Chronic Heart Failure – Pipeline Review, H1 2013
Fort Mills Times
Global Markets Direct’s, ‘Chronic Heart Failure – Pipeline Review, H1 2013′, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Chronic Heart Failure, complete with latest

and more »

16Apr/13

Research and Markets: Chronic Heart Failure – Pipeline Review, H1 2013 – Wall Street Journal

Research and Markets: Chronic Heart Failure – Pipeline Review, H1 2013
Wall Street Journal
Global Markets Direct’s, ‘Chronic Heart Failure – Pipeline Review, H1 2013′, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Chronic Heart Failure, complete with latest

and more »